BRPI0411626A - adjuvantes de matrizes e pìlulas de deposição com eles preparadas - Google Patents

adjuvantes de matrizes e pìlulas de deposição com eles preparadas

Info

Publication number
BRPI0411626A
BRPI0411626A BRPI0411626-7A BRPI0411626A BRPI0411626A BR PI0411626 A BRPI0411626 A BR PI0411626A BR PI0411626 A BRPI0411626 A BR PI0411626A BR PI0411626 A BRPI0411626 A BR PI0411626A
Authority
BR
Brazil
Prior art keywords
deposition
pills
adjuvants
matrix adjuvants
matrix
Prior art date
Application number
BRPI0411626-7A
Other languages
English (en)
Inventor
Chen Jianming
Yang Yuewu
Zhu Yonghong
Wang Wei
Zheng Zhigang
Yan Xijun
Lu Wenlang
Ye Zhengliang
Zhu Guoguang
Wang Shuangming
Original Assignee
Tianjin Tasly Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CN200410018761A external-priority patent/CN100592920C/zh
Application filed by Tianjin Tasly Pharmaceutical filed Critical Tianjin Tasly Pharmaceutical
Publication of BRPI0411626A publication Critical patent/BRPI0411626A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Inorganic Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

"ADJUVANTES DE MATRIZES E PìLULAS DE DEPOSIçãO COM ELES PREPARADAS". Presente invenção refere-se a adjuvantes de matrizes para pílulas de deposição. Os adjuvantes de matrizes para pílulas de deposição de acordo com a presente invenção compreendem novos adjuvantes de matrizes com ou sem os componentes plastificantes, que são tipicamente adjuvantes de matrizes naturais derivados de plantas seguros e não tóxicos. A presente invenção reduz a toxicidade causada por polietileno glicol, altera a situação de escassez de adjuvantes derivados de animais, aumenta a qualidade das pílulas de deposição e acelera o desenvolvimento de pílulas de deposição.
BRPI0411626-7A 2003-07-02 2004-07-02 adjuvantes de matrizes e pìlulas de deposição com eles preparadas BRPI0411626A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN03145615 2003-07-02
CN200410018761A CN100592920C (zh) 2004-03-17 2004-03-17 一种滴丸基质辅料及其滴丸制备方法
PCT/CN2004/000730 WO2005002547A1 (en) 2003-07-02 2004-07-02 Matrix adjuvants and the drop pills prepared with them

Publications (1)

Publication Number Publication Date
BRPI0411626A true BRPI0411626A (pt) 2006-08-08

Family

ID=33565761

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0411626-7A BRPI0411626A (pt) 2003-07-02 2004-07-02 adjuvantes de matrizes e pìlulas de deposição com eles preparadas

Country Status (9)

Country Link
US (1) US20070059358A1 (pt)
EP (1) EP1647269B1 (pt)
JP (1) JP5401013B2 (pt)
KR (2) KR101298256B1 (pt)
AU (2) AU2004253211B2 (pt)
BR (1) BRPI0411626A (pt)
CA (1) CA2530783C (pt)
RU (1) RU2354403C2 (pt)
WO (1) WO2005002547A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112013012184B1 (pt) 2010-11-16 2022-07-12 Provimi North America, Inc Suplemento de ração para gado
TWI492751B (zh) * 2013-06-04 2015-07-21 Univ Kaohsiung Medical 柴胡皂苷製備之醫藥組合物、其用途及其製備方法
US10743565B2 (en) 2013-10-02 2020-08-18 Can Technologies, Inc. Feed pellets and related systems and methods
JP6086857B2 (ja) * 2013-11-15 2017-03-01 ティーエスフーズ株式会社 冷凍餃子及び冷凍餃子の製造方法
CN105358220A (zh) * 2014-06-03 2016-02-24 高雄医学大学 柴胡皂苷制备的药物组合物、其用途及其制备方法
CN111772057B (zh) * 2020-07-23 2023-05-09 内江师范学院 一种提高鱼抗应激反应天然复合物及其应用
CN114903869B (zh) * 2022-05-16 2023-05-05 广州桔子创新科技有限公司 护理液爆珠、生产工艺和智能生产设备
CN116763749B (zh) * 2023-05-09 2025-09-19 迪沙药业集团有限公司 一种盐酸伊托必利药物组合物
CN118371185B (zh) * 2024-05-27 2025-04-01 江苏宝莱雅新材料科技有限公司 爆珠胶体自动滴定成型机及其滴定成型方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3341415A (en) * 1964-02-12 1967-09-12 Warner Lambert Pharmaceutical Pharmaceutical tablet excipients of solid particles of a binary solid solution of mannitol with a sugar
DE2343218C2 (de) * 1973-08-28 1986-08-07 Hoechst Ag, 6230 Frankfurt Furosemid enthaltende Pellets
US5075291A (en) * 1989-11-22 1991-12-24 Ici Americas Inc. Crystalline sugar alcohol containing uniformly dispersed particulate pharmaceutical compound
IE65045B1 (en) * 1990-04-28 1995-10-04 Takeda Chemical Industries Ltd Granulated preparations and method of producing the same
DE4200821A1 (de) * 1992-01-15 1993-07-22 Bayer Ag Geschmacksmaskierte pharmazeutische mittel
US5876754A (en) * 1992-01-17 1999-03-02 Alfatec-Pharma Gmbh Solid bodies containing active substances and a structure consisting of hydrophilic macromolecules, plus a method of producing such bodies
DE4413350A1 (de) * 1994-04-18 1995-10-19 Basf Ag Retard-Matrixpellets und Verfahren zu ihrer Herstellung
CN1052646C (zh) * 1995-03-23 2000-05-24 张涌川 一种治疗胃脘痛的胶丸及其制备方法
US5888538A (en) * 1995-03-29 1999-03-30 Warner-Lambert Company Methods and apparatus for making seamless capsules
WO1998042311A1 (en) * 1997-03-25 1998-10-01 Takeda Chemical Industries, Ltd. Gastrointestinal mucosa-adherent pharmaceutical composition
TW527195B (en) * 1997-10-09 2003-04-11 Ssp Co Ltd Fast-soluble solid pharmaceutical combinations
SE9704401D0 (sv) * 1997-11-28 1997-11-28 Astra Ab Matrix pellets for greasy, oily or sticky drug substances
FI107732B (fi) * 1998-03-18 2001-09-28 Xyrofin Oy Laktitolin kiteyttäminen, kiteinen laktitolituote ja sen käyttö
KR100341368B1 (ko) * 1999-08-18 2002-06-21 김춘란 심혈관 질환 치료제의 조성 및 그의 제조방법
EP1239844B1 (en) * 1999-12-20 2005-06-08 Nicholas J. Kerkhof Process for producing nanometer particles by fluid bed spray-drying
US8486464B2 (en) * 2000-12-22 2013-07-16 Tasly Pharmaceutical Group Co. Ltd. Herbal composition for angina pectoris, method to prepare same and uses thereof
BRPI0116589B1 (pt) 2000-12-22 2018-07-03 Tasly Pharmaceutical Group Co., Ltd. Composição herbal para angina pectoris, método para prepará-la e uso desta
JP2002255793A (ja) * 2001-02-28 2002-09-11 Morishita Jintan Kk 粒状製剤
CN1168444C (zh) * 2002-08-23 2004-09-29 张以成 硝苯地平滴丸剂及其制造方法
CN1301716C (zh) * 2002-10-09 2007-02-28 重庆太极医药研究院 磷酸苯丙哌啉缓释滴丸及制备工艺
CN1485028A (zh) * 2003-08-13 2004-03-31 广西北生集团科技开发有限公司 番茄红素滴丸

Also Published As

Publication number Publication date
CA2530783C (en) 2013-09-03
KR20120118082A (ko) 2012-10-25
WO2005002547A1 (en) 2005-01-13
JP2007508237A (ja) 2007-04-05
JP5401013B2 (ja) 2014-01-29
AU2009251014A1 (en) 2010-01-14
EP1647269A4 (en) 2009-05-13
RU2354403C2 (ru) 2009-05-10
KR101298256B1 (ko) 2013-08-22
AU2004253211A2 (en) 2005-01-13
AU2004253211A1 (en) 2005-01-13
AU2009251014B2 (en) 2011-04-21
EP1647269A1 (en) 2006-04-19
EP1647269B1 (en) 2017-04-12
KR20060030490A (ko) 2006-04-10
CA2530783A1 (en) 2005-01-13
US20070059358A1 (en) 2007-03-15
RU2005141403A (ru) 2007-08-10
AU2004253211B2 (en) 2009-09-17

Similar Documents

Publication Publication Date Title
CY1111661T1 (el) Μυκητοκτονες ενωσεις
EA200802390A1 (ru) Конъюгаты аналогов азиридилэпотилона и фармацевтические композиции, содержащие их
BR0308652A (pt) Composições e métodos para alteração do teor de tocotrienol
CR7742A (es) Formulaciones para uso veterinario que contienen productos de origen no animal
BR112012018839A2 (pt) "composição v´trea seca compreendendo um material bioativo"
BR0109118A (pt) Métodos para produzir plantas tolerantes a glifosato e composições disso
ECSP088109A (es) Composición agrícola
ECSP077999A (es) Formulaciones de una sal de bupropion de liberación modificada
AU2003230454A1 (en) Pet's chew and manufacture process
ZA200604322B (en) Method to reduce odor of excreta from companion animals
MX2008007307A (es) Granulos/capsulas modificados que contienen ingrediente activo.
TW200738144A (en) Fungicidal mixtures based on azolopyrimidinylamines
ECSP045239A (es) Composicion de ziprasidona y controles sinteticos
CL2007001205A1 (es) Compuestos derivados de n-fenil-3-tio-4-fenil-azetedin-2-ona; procedimiento de preparacion; composicion farmaceutica; combinacion; uso en el tratamiento de una condicion hiperlipidemica, ateroesclerosis, alzheimer y tumores asociados a colesterol
BRPI0307155A8 (pt) plantas transgênicas expressando proteínas modificadas por civps ou inteínas e método relativo
TW200633719A (en) Glycoconjugate vaccines containing peptidoglycan
BR0316305A (pt) Composto ou um sal farmaceuticamente aceitável do mesmo, métodos para tratar a dor em um animal, para estimular a função do receptor opióide em uma célula, para preparar uma composição, e para tratar diarréia em um animal, composição, e kit
BRPI0411626A (pt) adjuvantes de matrizes e pìlulas de deposição com eles preparadas
BRPI0516727A (pt) métodos para tratar um linfoma positivo em cd30 , para inibir o crescimento de uma célula que expressa cd30, e para tratar ou prevenir uma doença
AR061093A1 (es) Composiciones de calcio
BRPI0418365A (pt) ativação por planta de toxina de inseto
MXPA05000765A (es) Compuestos de 5-ariltetrazola, composiciones de los mismos y usos para los mismos.
BRPI0401103A (pt) Composição compósita, método para formar a mesma, composição modificada, e, método para formar a mesma
PT1965809E (pt) Composições para melhorar a saúde do intestino e o rendimento animal compreendendo beta-glucanos e alfa-fucanos
BR0011174A (pt) Composições, compostos, compostos isolados e métodos para controlar pestes

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25F Entry of change of name and/or headquarter and transfer of application, patent and certif. of addition of invention: change of name on requirement

Owner name: TIANJIN TASLY PHARMACEUTICAL CO. (CN)

Free format text: A FIM DE ATENDER AS ALTERACOES DE NOME E ENDERECO REQUERIDAS ATRAVES DA PETICAO NO 18120045810/SP, DE 12/12/2012, E NECESSARIO APRESENTAR A DOCUMENTACAO DE ALTERACAO DEVIDAMENTE NOTARIZADA E COM A LEGALIZACAO CONSULAR, UMA GUIA RELATIVA AO SEGUNDO SERVICO SOLICITADO, ALEM DA GUIA DE CUMPRIMENTO DE EXIGENCIA.

B25L Entry of change of name and/or headquarter and transfer of application, patent and certificate of addition of invention: publication cancelled

Owner name: TIANJIN TASLY PHARMACEUTICAL CO. (CN)

Free format text: ANULADA A EXIGENCIA PUBLICADA NA RPI NO 2223, DE 13/08/2013, POR TER SIDO INDEVIDA, UMA VEZ QUE FOI FEITA COM INCORRECAO.

B25D Requested change of name of applicant approved

Owner name: TASLY PHARMACEUTICAL GROUP CO., LTD. (CN)

B25I Requirement for requested change of headquarter

Owner name: TASLY PHARMACEUTICAL GROUP CO., LTD. (CN)

Free format text: A FIM DE ATENDER A(S) ALTERACAO(OES) DE ENDERECO(S) REQUERIDA(S) ATRAVES DA PETICAO NO 018120045810-SP, DE 12/12/2012, E NECESSARIO RECOLHER AS GUIAS REFERENTES A ESTE SERVICO E AO CUMPRIMENTO DESTA EXIGENCIA.

B25G Requested change of headquarter approved

Owner name: TASLY PHARMACEUTICAL GROUP CO., LTD. (CN)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B15K Others concerning applications: alteration of classification

Free format text: AS CLASSIFICACOES ANTERIORES ERAM: A61K 9/20 , A61K 47/26 , A61K 47/36 , A61K 47/38 , A61K 47/40

Ipc: A61K 9/20 (2006.01), A61K 47/26 (2006.01), A61K 47

B07A Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette]
B07A Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal: appeal against refusal